Updated:
Radon Medical Imaging
Radon Medical Imaging deploys capital into diagnostic imaging assets — MRI, CT, and X-ray systems — under long-term contracts with US healthcare providers.
Radon Medical Imaging
Radon Medical Imaging structures its capital around the lifecycle of high-value medical imaging equipment. The firm deploys into direct asset ownership, acquiring both new and refurbished modalities from manufacturers and secondary markets, then places them under long-term contracts with hospitals, clinics, and private practices. Its portfolio spans MRI, CT, PET/CT, nuclear medicine, and general radiography systems, with a geographic footprint serving healthcare providers throughout the United States. The model combines equipment financing, leasing, and asset management under a single investment structure. Rather than committing to traditional fund vehicles or outside LPs, the firm operates through direct balance-sheet deployment — acquiring systems outright and managing the residual value risk. This creates an inflation-linked, hard-asset portfolio of essential clinical infrastructure with contracted cash flows from healthcare operators. Scale, team size, and specific deployment volumes remain undisclosed in public records. The firm does not maintain a visible institutional marketing presence, consistent with a privately capitalized structure that sources deals directly through equipment brokers, OEM relationships, and regional healthcare networks rather than broad intermediary channels. Where Radon Medical Imaging structurally differs from a generic leasing company or healthcare lender is in its pure-play concentration on imaging hardware as the primary asset class. By avoiding real estate, receivables, or operating-company equity, the firm builds a specialized book of equipment assets where value derives from clinical utility, regulatory depreciation schedules, and secondary-market liquidity — a narrower mandate than diversified healthcare credit or private equity strategies in the same sector.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
United States
Sector focus
Frequently asked questions
How does Radon Medical Imaging generate return on its imaging assets?
The firm acquires imaging equipment and places it with healthcare providers under structured lease or service contracts, generating recurring cash flows from the asset. At end-of-term, additional return is realized through secondary market resale or re-deployment to another clinical site. The model is built on the residual value and utility lifespan of the equipment itself.
Is Radon Medical Imaging an operating company or an investment firm?
It operates at the intersection of both. The entity buys and owns the equipment outright — an investment function — while also managing the logistics of installation, maintenance coordination, and end-of-term disposition, which are typical operating-company responsibilities. This integrated approach distinguishes it from pure financing companies that never take title to the assets.
What types of imaging equipment does the firm invest in?
Radon Medical Imaging covers the major diagnostic modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), X-ray, ultrasound, and nuclear medicine systems. The firm deals in both new systems sourced from manufacturers and refurbished units acquired on the secondary market.
Who are the end-users of Radon Medical Imaging's equipment?
The firm contracts with a range of US healthcare providers — hospitals, outpatient imaging centers, physician practices, and specialty clinics — that need diagnostic imaging capability without committing the full upfront capital expenditure to purchase systems outright.
Does Radon Medical Imaging raise outside capital or operate as a fund?
The firm does not publicly market itself as a fund sponsor seeking limited partners. Its investment posture is consistent with privately sourced balance-sheet capital deployed directly into hard assets, without the closed-end fund structures or LP reporting obligations typical of institutional healthcare investment managers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: